Ironwood Pharmaceuticals Inc financial data

Symbol
IRWD on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Summer Street, Suite 2300, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 90.9 % -96.9%
Return On Equity 312 % +964%
Return On Assets -207 % -1312%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 159M shares +2.32%
Common Stock, Shares, Outstanding 159M shares +2.32%
Entity Public Float 1.47B USD -5.77%
Common Stock, Value, Issued 159K USD +2.58%
Weighted Average Number of Shares Outstanding, Basic 158M shares +2.1%
Weighted Average Number of Shares Outstanding, Diluted 158M shares -15.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 414M USD -0.86%
Research and Development Expense 129M USD +179%
Costs and Expenses 1.41B USD +756%
Operating Income (Loss) -995M USD -494%
Nonoperating Income (Expense) -14.5M USD -257%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.01B USD -485%
Income Tax Expense (Benefit) 72.5M USD -9.24%
Net Income (Loss) Attributable to Parent -1.05B USD -678%
Earnings Per Share, Basic -6.78 USD/shares -670%
Earnings Per Share, Diluted -6.79 USD/shares -772%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 122M USD -83.6%
Accounts Receivable, after Allowance for Credit Loss, Current 72M USD -37.8%
Assets, Current 208M USD -76%
Deferred Income Tax Assets, Net 206M USD -23%
Property, Plant and Equipment, Net 5.29M USD -12.1%
Operating Lease, Right-of-Use Asset 12.2M USD -10.7%
Other Assets, Noncurrent 3.4M USD +314%
Assets 439M USD -62%
Accounts Payable, Current 6.22M USD +5173%
Employee-related Liabilities, Current 12.3M USD +30.9%
Contract with Customer, Liability, Current 1.7M USD
Liabilities, Current 252M USD +959%
Operating Lease, Liability, Noncurrent 14M USD -13%
Other Liabilities, Noncurrent 29.4M USD +149%
Accumulated Other Comprehensive Income (Loss), Net of Tax -922K USD
Retained Earnings (Accumulated Deficit) -1.7B USD -162%
Stockholders' Equity Attributable to Parent -331M USD -147%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -331M USD -147%
Liabilities and Equity 439M USD -62%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 45M USD -43.9%
Net Cash Provided by (Used in) Financing Activities -15.6M USD -491%
Net Cash Provided by (Used in) Investing Activities -68K USD -423%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 159M shares +2.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.4M USD -65.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 122M USD -83.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13.6M USD +136%
Deferred Tax Assets, Valuation Allowance 85.6M USD +2704%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 301M USD +3.74%
Operating Lease, Liability 17.1M USD -10.6%
Depreciation 513K USD +79.4%
Payments to Acquire Property, Plant, and Equipment 68K USD +423%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.05B USD -679%
Lessee, Operating Lease, Liability, to be Paid 20.4M USD -13.1%
Property, Plant and Equipment, Gross 14.5M USD -15.1%
Operating Lease, Liability, Current 3.14M USD +2.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.25M USD +1.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.19M USD +2.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 72.6M USD +10.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.25M USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.32M USD +2.03%
Deferred Tax Assets, Operating Loss Carryforwards 105M USD +18.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 47.9M USD -8.29%
Current Income Tax Expense (Benefit) 10.9M USD -5.9%
Preferred Stock, Shares Authorized 75M shares 0%
Unrecognized Tax Benefits 98.2M USD -4.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.38M USD +2.02%
Operating Lease, Payments 773K USD +2.11%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 10.6M USD -8.87%
Depreciation, Depletion and Amortization 1.2M USD -14.3%
Share-based Payment Arrangement, Expense 60.8M USD +116%
Deferred State and Local Income Tax Expense (Benefit) 24.7M USD +82.3%
Interest Expense 27.3M USD +303%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%